Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Nova Mentis Life Science Corp. C.LIB

Nova Mentis Life Science Corp is a Canadian-based company focused on building and supporting a diversified portfolio of health and wellness businesses. Through its subsidiary, the company is focused on exploring the anti-inflammatory effects of psilocybin in underexplored metabolic indications such as obesity and diabetes and providing a Health Canada Standard Licensed facility focused on the cultivation of AAAA premium, small batch, terpene rich dominant cultivars cured to perfection.


CSE:LIB - Post by User

Post by dereklafreenon Nov 29, 2018 11:23am
169 Views
Post# 29039663

Too late..........NR

Too late..........NR

 

ORIGINAL: Liberty Leaf Announces Affirmation of Readiness Submission to Health Canada by Just Kush

 

2018-11-29 08:11 PT - News Release

 

Liberty Leaf Announces Affirmation of Readiness Submission to Health Canada by Just Kush

Canada NewsWire

VANCOUVER, Nov. 29, 2018 /CNW/ - Liberty Leaf Holdings Ltd. (CSE: LIB) (OTCQB: LIBFF) (FSE: HN3P) ("Liberty Leaf" or the "Company") is pleased to announce that its subsidiary, Just Kush Enterprises Ltd. ("Just Kush"), submitted its Affirmation of Readiness ("AOR") evidence package to Health Canada on November 29, 2018.

This submission is the final stage in Just Kush's strategy and efforts to obtain regulatory approval for Cannabis Licensing, which has included the buildout and upgrading of its facility, and compliance with all of Health Canada's Cannabis Licensing requirements. The AOR submission was orchestrated and shepherded by Cannabis Compliance Inc. ("CCI"), a respected firm with a proven track record for success in this area.

Completion of the AOR involved certifying the readiness of the facility itself, and producing an attestation video and comprehensive report with evidence supporting the Company's adherence to Health Canada's standards and requirements for Cannabis Licensing.

"We are extremely gratified that we have reached the culmination of all our planning and efforts to effect the AOR submission," said Will Rascan, President and CEO of Liberty Leaf. "Special thanks goes out to the hard work by the Just Kush team. Our confidence level in the success of this submission, as well as the expertise of CCI as a part of the team, is exceptionally high."

Just Kush Quality Manager, Robert Jackman, is very pleased with the results: "The due diligence on the part of everyone involved has really paid off. It was very important to take the time to get this right, and to draw upon the efforts of the experts we brought in."

About Just Kush

Just Kush plans to cultivate premium strains of cannabis, selected for different levels of CBDs and THCs.

The company has a production facility situated on 13 acres in the Okanagan Valley near Oliver, B.C. and is currently in control of an MMAR licence to cultivate medicinal cannabis. It is also an applicant for cannabis licenses that will enable it to cultivate, process and sell cannabis for the medicinal and recreational markets.

With legalization of recreational cannabis in Canada, Just Kush plans to scale-up its proprietary craft grow technologies. With attention to detail, and aeroponic small-batch methods, production can be scaled to satisfy the demands of both the much larger recreational market that has now become a reality in Canada and medicinal markets globally.

About Liberty Leaf

Liberty Leaf Holdings Ltd. is a Canadian-based, public company whose focus is to build and support a diversified portfolio of cannabis-sector businesses, including cultivation, processing, value-added CBD pet products and supply-chain products within this dynamic and fast-growing sector.

Liberty Leaf's late-stage ACMPR portfolio consists of a 60% interest in Just Kush and 100% of North Road Ventures. The company has also recently launched its Signature Cannabis Retail division, bringing recreational cannabis and accessories to market for consumers.

On Behalf of the Board

Will Rascan, President & CEO
Liberty Leaf Holdings Ltd.
Phone: 778-819-0244
Toll Free: 1-833-LIB-LEAF (542-5323)

Twitter: @LibertyLeafCSE
Facebook: LibertyLeafCSE

Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release may contain forward-looking statements based on assumptions and judgments of management regarding future events or results. Such statements are subject to a variety of risks and uncertainties, which could cause actual events or results to differ materially from those reflected in the forward-looking statements. The Company disclaims any intention or obligation to revise or update such statements.

SOURCE Liberty Leaf Holdings

View original content to download multimedia: https://www.newswire.ca/en/releases/archive/November2018/29/c8704.html

Contact:

on the Company please visit https://www.libleaf.com or email info@libleaf.com

<< Previous
Bullboard Posts
Next >>